Intriguingly, we found that the PCa patients with tumors having higher expression levels of RFX6 while carrying homozygous risk genotype TT at rs339331 were strongly associated with increased risk of biochemical recurrence and metastasis (Fig. 8g, i). The gene discussed is RFX6; the disease is posterior cortical atrophy.